BIOMARIN PHARMACEUTICAL INC (BMRN) Other Assets, Noncurrent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Biomarin Pharmaceutical Inc quarterly Other Assets, Noncurrent history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Other Assets, Noncurrent for the quarter ending March 31, 2024 was $185 M, a 23.1% increase year-over-year.
Other Assets, Noncurrent, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $185 M +$34.7 M +23.1% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $172 M -$4.7 M -2.67% Dec 31, 2023 10-Q 2024-04-26
Q3 2023 $165 M +$13.3 M +8.75% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $144 M -$7.63 M -5.03% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $150 M +$871 K +0.58% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $176 M +$24.1 M +15.9% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $152 M +$7.08 M +4.9% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $152 M +$10.1 M +7.15% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $149 M +$7.99 M +5.66% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $152 M +$9.88 M +6.95% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $145 M +$25.7 M +21.6% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $142 M +$5.81 M +4.28% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $141 M +$15.3 M +12.1% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $142 M +$20.2 M +16.6% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $119 M +$6.36 M +5.65% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $136 M +$36.4 M +36.6% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $126 M +$29.6 M +30.8% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $122 M +$85.4 M +234% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $113 M +$75.1 M +200% Sep 30, 2019 10-Q/A 2019-11-04
Q2 2019 $99.5 M +$60 M +152% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $96.3 M +$63.6 M +195% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $36.6 M +$6.72 M +22.5% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $37.6 M +$14.6 M +63.4% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $39.4 M +$18 M +83.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $32.7 M +$6.09 M +22.9% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $29.9 M -$2.96 M -9.03% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $23 M -$13.5 M -36.9% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $21.4 M -$1.61 M -6.98% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $26.6 M +$1.18 M +4.65% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $32.8 M -$376 M -92% Dec 31, 2016 10-K 2018-02-26
Q3 2016 $36.4 M -$24.3 M -40.1% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $23.1 M -$35.2 M -60.4% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $25.4 M -$54.9 M -68.4% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 $409 M +$354 M +649% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $60.8 M -$742 K -1.21% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $58.3 M +$11.7 M +25.2% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $80.3 M +$38.8 M +93.4% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $54.6 M -$102 M -65.1% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $61.5 M +$47.5 M +339% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 $46.6 M +$31.7 M +213% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $41.5 M +$26.4 M +174% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $156 M +$137 M +699% Dec 31, 2013 10-K 2015-03-02
Q3 2013 $14 M -$5.73 M -29% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 $14.9 M -$5.18 M -25.8% Jun 30, 2013 10-Q 2013-07-29
Q1 2013 $15.2 M -$4.69 M -23.6% Mar 31, 2013 10-Q 2013-04-29
Q4 2012 $19.5 M +$4.05 M +26.1% Dec 31, 2012 10-K 2014-02-26
Q3 2012 $19.7 M +$6.18 M +45.6% Sep 30, 2012 10-Q 2012-10-29
Q2 2012 $20.1 M +$7.79 M +63.5% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 $19.8 M +$7.62 M +62.3% Mar 31, 2012 10-Q 2012-04-30
Q4 2011 $15.5 M +$1.28 M +9.01% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $13.6 M -$215 M -94.1% Sep 30, 2011 10-Q 2011-10-31
Q2 2011 $12.3 M -$2.29 M -15.7% Jun 30, 2011 10-Q 2011-08-01
Q1 2011 $12.2 M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 $14.2 M Dec 31, 2010 10-K 2012-02-22
Q3 2010 $229 M Sep 30, 2010 10-Q 2010-10-29
Q2 2010 $14.6 M Jun 30, 2010 10-Q 2010-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.